• Cambrex can reliably develop and manufacture a broad spectrum of HPAPIs and compounds.

  • Our dedication to quality and safety of energetic chemistry has laid a solid foundation for supplying cGMP high energy compounds to world-leading pharmaceutical companies.

  • Cambrex is the small molecule company that provides drug substance, drug product and analytical services across the entire drug lifecycle.

  • Cambrex holds US Drug Enforcement Agency (DEA) licenses for process research, development, manufacturing and importation of Schedule I to IV controlled substances.

  • Our team of experts can assess processes for suitable application of continuous flow culminating in the custom development of processes incorporating proof-of-concept to cGMP manufacturing and commercialization.

  • Biocatalysis enables cost efficient and environmentally friendly manufacturing through enzymatic synthesis and provides pure -regio, chemo- and enantioselective compounds when compared to traditional chemical synthesis.